[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100306272":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":33,"responsibleParty":53,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":10,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":69,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"New York Presbyterian Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"alcohol liver disease",null,"Patients with alcohol liver disease consenting to participate in the study will be administered an initial survey at inclusion and then follow-up surveys at 3, 6, 9, 12, 15, and 18 month intervals and then 2, 5, and 10 years. There is no intervention cohort, all enrolled will complete the same surveys. Recidivism will be measured by responses to survey questions, clinical interviews documented in the chart, and urine ethnyl glucuronide or blood ethanol testing.",[13],"Other: survey",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"survey","surveys will be administered at inclusion and follow-ups",[9],[20],{"name":21,"affiliation":22,"role":23},"Robert S Brown, MD, MPH","New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Nicole T Shen, MD","CONTACT","3146095911","nts9004@nyp.org",{"name":21,"role":27,"phone":31,"phoneExt":10,"email":32},"(646) 962-5483","rsb2005@med.cornell.edu",[34],{"facility":22,"status":35,"city":36,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","New York","10021","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-74.00597,40.71427,{"lat":44,"lon":43},[47,49],{"name":26,"role":27,"phone":48,"phoneExt":10,"email":29},"314-609-5911",{"name":50,"role":27,"phone":51,"phoneExt":10,"email":52},"Cecilia M Mero","(646) 962-9358","cmm2002@med.cornell.edu",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Nicole T Shen","Gastroenterology and Hepatology Fellow Physician","100306272","evaluating-alcohol-use-in-alcoholic-liver-disease-100306272",false,"NCT03267069","Evaluating Alcohol Use in Alcoholic Liver Disease","Inclusion Criteria:\n\n* alcoholic liver disease able to consent\n\nExclusion Criteria:\n\n* without alcoholic liver disease unable to consent","ALL","18 Years","80 Years",{"count":67,"type":68},160,"ESTIMATED","10 Years","OBSERVATIONAL","This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.",[73],"Alcoholic Liver Disease","2019-03-11",{"date":76,"type":77},"2019-03-13","ACTUAL",{"date":79,"type":77},"2016-11-27",{"date":81,"type":68},"2027-11-01",{"name":55,"class":6},1]